Literature DB >> 10693928

ErbB-4 activation promotes neurite outgrowth in PC12 cells.

A Vaskovsky1, Z Lupowitz, S Erlich, R Pinkas-Kramarski.   

Abstract

Neu differentiation factor (NDF; also known as neuregulin) induces a pleiotropic cellular response that is cell type-dependent. NDF and its receptor ErbB-4 are highly expressed in neurons, implying important roles in neuronal cell functions. In the present study we demonstrate that ErbB-4 receptors expressed in PC12 cells mediate NDF-induced signals and neurite outgrowth that are indistinguishable from those mediated by the nerve growth factor-activated Trk receptors. In PC12-ErbB-4 cells but not in PC12 cells, NDF induced an initial weak mitogenic signal and subsequently neurite outgrowth. The NDF-induced differentiation in PC12-ErbB-4 cells was mimicked by the pan-ErbB ligand betacellulin but not by other epidermal growth factor-like ligands. Thus, NDF and betacellulin mediate similar activities through the ErbB-4 receptor. Indeed, only these ligands induced strong phosphorylation of the ErbB-4 receptors. Neurite outgrowth induced by NDF in PC12-ErbB-4 cells was accompanied by sustained activation of mitogen-activated protein kinase (MAPK) and induction of the neural differentiation marker GAP-43. Inhibition of the MAPK kinase MEK or of protein kinase C (PKC) blocked NDF-induced differentiation, whereas elevation of cyclic AMP levels enhanced the response. Taken together, these results indicate that neurite outgrowth induced by ErbB-4 in PC12 cells requires MAPK and PKC signaling networks.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10693928     DOI: 10.1046/j.1471-4159.2000.0740979.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  31 in total

Review 1.  ErbB-4: a receptor tyrosine kinase.

Authors:  W Zhou; G Carpenter
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

Review 2.  Neuregulin signaling via erbB receptor assemblies in the nervous system.

Authors:  Sean Murphy; Randy Krainock; Muly Tham
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

3.  Colostrinin-driven neurite outgrowth requires p53 activation in PC12 cells.

Authors:  Attila Bacsi; G John Stanton; Thomas K Hughes; Marian Kruze; Istvan Boldogh
Journal:  Cell Mol Neurobiol       Date:  2005-11       Impact factor: 5.046

4.  Neuregulins rescue PC12-ErbB-4 cells from cell death induced by beta-amyloid peptide: involvement of PI3K and PKC.

Authors:  Ayelet Di Segni; Ezra Shaharabani; Reuven Stein; Ronit Pinkas-Kramarski
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

5.  Integrated analysis of receptor activation and downstream signaling with EXTassays.

Authors:  Anna Botvinnik; Sven P Wichert; Tobias M Fischer; Moritz J Rossner
Journal:  Nat Methods       Date:  2009-12-13       Impact factor: 28.547

6.  PrPSc accumulation in neuronal plasma membranes links Notch-1 activation to dendritic degeneration in prion diseases.

Authors:  Stephen J Dearmond; Krystyna Bajsarowicz
Journal:  Mol Neurodegener       Date:  2010-01-21       Impact factor: 14.195

7.  PI3K and Erk MAPK mediate ErbB signaling in Xenopus gastrulation.

Authors:  Shuyi Nie; Chenbei Chang
Journal:  Mech Dev       Date:  2007-07-19       Impact factor: 1.882

8.  ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms.

Authors:  Daria Krivosheya; Lucia Tapia; Joshua N Levinson; Kun Huang; Yunhee Kang; Rochelle Hines; Annie K Ting; Ann Marie Craig; Lin Mei; Shernaz X Bamji; Alaa El-Husseini
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

9.  ErbB4 promotes cyclooxygenase-2 expression and cell survival in colon epithelial cells.

Authors:  Mark R Frey; Valda C Hilliard; Matthew T Mullane; D Brent Polk
Journal:  Lab Invest       Date:  2010-06-28       Impact factor: 5.662

Review 10.  Neuregulin 1 in neural development, synaptic plasticity and schizophrenia.

Authors:  Lin Mei; Wen-Cheng Xiong
Journal:  Nat Rev Neurosci       Date:  2008-05-14       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.